This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the recent interim results from the Phase 2 PRISM clinical trial of intravitreal 4D-150 in patients with wet AMD
Ticker(s): FDMTWho's the expert?
Institution: Lions Sightfirst Eye Hospital
- Medical Director at Lions Sightfirst Eye Hospital Loresho.
- Manages 50 patients with Wet AMD.
Interview Goalto discuss the current standard of care and the potential of intravitreal 4D-150 being developed by 4DMT for the treatment of wet AMD.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
